Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study

1. García-Sáenz, J.A.
2. Marmé, F.
3. Untch, M.
4. Bonnefoi, H.
5. Kim, S.-B.
6. Bear, H.
7. Mc Carthy, N.
8. Gelmon, K.
9. Martin, M.
10. Kelly, C.M.
11. Reimer, T.
12. Toi, M.
13. Law, E.
14. Bhattacharyya, H.
15. Gnant, M.
16. Makris, A.
17. Seiler, S.
18. Burchardi, N.
19. Nekljudova, V.
20. Loibl, S.
21. Rugo, H.S.